Investigators using targeted proteomics — a technique to detect proteins of interest — on samples of ovarian cancer found a wide variety of biomarkers that might help predict which chemotherapies patients are more likely to respond to, the precision medicines company mProbe reported. Identifying these tumor biomarkers is crucial not only to spotting potential targets for future therapies, but also for enabling physicians and patients to make more informed decisions and avoid unnecessary chemo use, the investigators said. Findings were…
You must be logged in to read/download the full post.
The post Protein Biomarkers to Gauge Cancer Response to Chemo Identified appeared first on BioNewsFeeds.